| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0929-693X(12)71108-9 |
| P698 | PubMed publication ID | 22682490 |
| P2093 | author name string | D Hubert | |
| O Launay | |||
| J Gaudelus | |||
| L Iordache | |||
| P2860 | cites work | Cystic Fibrosis: Pathogenesis and Future Treatment Strategies | Q22305426 |
| Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis | Q24240779 | ||
| Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis | Q28297061 | ||
| Exacerbations in cystic fibrosis: 2 . prevention. | Q30480308 | ||
| Influenza-associated cystic fibrosis pulmonary exacerbations. | Q33776832 | ||
| The changing microbial epidemiology in cystic fibrosis | Q33825634 | ||
| Efficacy of pneumococcal conjugate vaccines in large scale field trials | Q33899670 | ||
| Influenza vaccination in adults with cystic fibrosis | Q35180693 | ||
| The evolution of liver disease in cystic fibrosis. | Q35264319 | ||
| An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children | Q35618211 | ||
| Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials | Q35710192 | ||
| Acute severe deterioration in cystic fibrosis associated with influenza A virus infection | Q36256324 | ||
| Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis | Q37125716 | ||
| Impact of Staphylococcus aureus on the pathogenesis of chronic cystic fibrosis lung disease | Q37789094 | ||
| Varicella-zoster infection in adults with cystic fibrosis: role of acyclovir | Q39325005 | ||
| Bacterial Infection in Cystic Fibrosis | Q39521979 | ||
| Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. | Q39972823 | ||
| Immunisation in the current management of cystic fibrosis patients | Q40410972 | ||
| Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark | Q41145157 | ||
| Mediastinal tuberculosis in an adult patient with cystic fibrosis | Q42625567 | ||
| Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis | Q44324883 | ||
| Decreased T helper cell function in patients with cystic fibrosis. | Q45288105 | ||
| Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis | Q45723625 | ||
| Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection | Q47969223 | ||
| Infection, inflammation, and lung function decline in infants with cystic fibrosis. | Q51578835 | ||
| Pertussis vaccines: WHO position paper--recommendations. | Q53163070 | ||
| Live attenuated versus inactivated influenza vaccine in infants and young children. | Q55043222 | ||
| Cystic fibrosis | Q55881299 | ||
| Poliomyelitis and tetanus immunization: antibody responses in patients with cystic fibrosis | Q71734242 | ||
| Natural history of liver disease in cystic fibrosis | Q73114499 | ||
| Preimmunization anti-pneumococcal antibody levels are protective in a majority of patients with cystic fibrosis | Q74582842 | ||
| Cystic fibrosis complicated by multiresistant tuberculosis | Q79297361 | ||
| Low gammaglobulin subclass 2 levels in paediatric cystic fibrosis patients followed over a 2-year period | Q79448946 | ||
| Cystic fibrosis-associated liver disease: a population-based study | Q80517955 | ||
| Is there a role for influenza vaccination in cystic fibrosis? | Q80579466 | ||
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | S36-9 | |
| P577 | publication date | 2012-05-01 | |
| P1433 | published in | Archives de Pediatrie | Q15757206 |
| P1476 | title | [Vaccination of cystic fibrosis patients] | |
| P478 | volume | 19 Suppl 1 |
Search more.